Osteoinductive pharmaceutical formulations

Details Osteoinductive pharmaceutical formulations Osteoinductive pharmaceutical formulations

1990-06-18

1994-11-15

Moezie, F. T.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 21, 514 8, 530350, 530399, A61K 3736

Patent

active

053648390

ABSTRACT:
Osteoinductive pharmaceutical formulations comprising antifibrinolytic agents such as epsilon amino acid caproic acid or other lysine analogues or serine protease inhibitors and cartilage and/or bone inductive proteins are disclosed. These formulations are useful in the treatment of cartilage and/or bone defects.

REFERENCES:
patent: 4186448 (1980-02-01), Brekke
patent: 4430760 (1984-02-01), Smestad
patent: 4440750 (1984-04-01), Glowacki et al.
patent: 4563489 (1986-01-01), Urist
patent: 4596574 (1986-06-01), Urist
patent: 4652441 (1987-03-01), Okada
patent: 4795804 (1989-01-01), Urist
patent: 4877864 (1989-10-01), Wang
patent: 4902296 (1990-02-01), Bolander et al.
patent: 4968590 (1990-11-01), Kuberasampath et al.
patent: 4979959 (1990-12-01), Guire
patent: 5013649 (1991-05-01), Wang
patent: 5106748 (1992-04-01), Wozney
patent: 5141905 (1992-08-01), Rosen
Nilsson, I. et al., The Lancet: 1322-1326 (1960).
Brandstedt, S. et al., Eur. Surgical Res. 12:12-21 (1980).
Kawamura, Morio, et al., Clinical Orthopaedics and Related Research , 235(10): 302-310 (1988).
Wozney et al., Science, 242, 1528-1534, 1988.

Affiliated with

Also associated with

Rating

Osteoinductive pharmaceutical formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Osteoinductive pharmaceutical formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Osteoinductive pharmaceutical formulations will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1097800